GlassScriptPhysician profile
Rami Jirjis
NPI 1720584584
$5,118.77
in general payments reported to CMS, 2019-2025
26 companies · $964 in 2025
The $964 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $103 · 2021: $91.91 · 2022: $245 · 2023: $3,032 · 2024: $683 · 2025: $964.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,224 · Travel and Lodging: $1,355 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,223.94 |
| Travel and Lodging | $1,354.68 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $1,253.70 | 2023 | Cook, S~Curve |
| Cook Incorporated | $751.80 | 2023 | Fiber Dust |
| Boston Scientific Corporation | $570.47 | 2019-2025 | Lithovue, Ams 700, Spaceoar Vue System - 10ml |
| Procept Biorobotics Corporation | $374.97 | 2023-2025 | Aquabeam Robotic System, Aquabeam System |
| Sumitomo Pharma America, INC. | $313.77 | 2023-2025 | Gemtesa, Orgovyx |
| Convatec INC. | $242.11 | 2023-2025 | |
| Janssen Biotech, INC. | $204.88 | 2024-2025 | Erleada |
| Myriad Genetic Laboratories, INC. | $201.72 | 2023-2024 | Prolaris |
| Pfizer INC. | $167.20 | 2023-2025 | |
| Olympus America INC. | $133.73 | 2022 | |
| Endo USA, INC. | $125.87 | 2024-2025 | Xiaflex |
| Astrazeneca Pharmaceuticals LP | $124.74 | 2023 | Lynparza |
| Allergan, INC. | $91.91 | 2021 | |
| Antares Pharma, INC. | $85.61 | 2024-2025 | Xyosted |
| Medtronic, INC. | $71.99 | 2025 | Interstim |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $62.88 | 2024-2025 | Xtandi |
| Urogen Pharma, INC. | $56.45 | 2023-2025 | Jelmyto |
| Bayer Healthcare Pharmaceuticals INC. | $55.39 | 2025 | |
| Teleflex LLC | $53.17 | 2024 | Urolift |
| Endo Pharmaceuticals INC. | $52.21 | 2023-2024 | Xiaflex |
| Abbvie INC. | $27.80 | 2024 | |
| Laborie Medical Technologies Corp. | $24.46 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| 180 Medical, INC. | $23.01 | 2024 | |
| Integra Lifesciences Corporation | $19.00 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Merck Sharp & Dohme LLC | $15.84 | 2023 | Keytruda, Lynparza |
| Innovation Technologies INC | $14.09 | 2023 | Irrisept |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rami Jirjis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.